Skip to Content

Eprosartan Side Effects

For the Consumer

Applies to eprosartan: oral tablet

Along with its needed effects, eprosartan may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking eprosartan:

Less common Rare
  • Dizziness, lightheadedness, or fainting
  • swollen face, lips, limbs, or tongue

Some side effects of eprosartan may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common or rare
  • Abdominal or stomach pain
  • joint pain
  • unusual tiredness

For Healthcare Professionals

Applies to eprosartan: oral tablet


The most common adverse reactions were headache and unspecific gastrointestinal complaints.[Ref]

Nervous system

Very common (10% or more): Headache (up to 11%)
Common (1% to 10%): Dizziness
Frequency not reported: Ataxia, migraine, neuritis, paresthesia, somnolence, tremor, vertigo, tinnitus[Ref]


Common (1% to 10%): Unspecific gastrointestinal complaints, abdominal pain, diarrhea, dyspepsia
Frequency not reported: Constipation, dry mouth, esophagitis, flatulence, gastritis, gastroenteritis, gingivitis, nausea, periodontitis, toothache, vomiting[Ref]


Common (1% to 10%): Rhinitis, upper respiratory tract infection, pharyngitis, coughing, sinusitis, dyspnea, bronchitis
Frequency not reported: Asthma, epistaxis[Ref]


Common (1% to 10%): Asthenia, injury, chest pain, fatigue, pain
Uncommon (0.1% to 1%): Facial edema
Frequency not reported: Substernal chest pain, peripheral edema, fever, influenza-like symptoms, malaise[Ref]


Common (1% to 10%): Myalgia, arthralgia, back pain
Frequency not reported: Rigors, creatine phosphokinase increased, arthritis, arthritis aggravated, arthrosis, skeletal pain, tendinitis, leg cramps[Ref]


Common (1% to 10%): Palpitation, dependent edema
Uncommon (0.1% to 1%): Hypotension
Frequency not reported: Hot flushes, angina pectoris, bradycardia, ECG abnormal, ECG specific abnormal, extrasystoles, atrial fibrillation, tachycardia, peripheral ischemia[Ref]


Common (1% to 10%): Neutrophils 1500/mm3 or less
Uncommon (0.1% to 1%): Hemoglobin decreased greater than 20%, WBC count of 3000/mm3 or less, platelets 100 x 10(9)/L or less
Frequency not reported: Anemia, leukopenia[Ref]


Common (1% to 10%): Hypertriglyceridemia
Uncommon (0.1% to 1%): Potassium 5.6 mmol/L or greater
Frequency not reported: Alcohol intolerance, anorexia, diabetes mellitus, gout, hypercholesterolemia, hyperglycemia, hyperkalemia, hypokalemia, hyponatremia[Ref]


Common (1% to 10%): Allergic skin reactions
Uncommon (0.1% to 1%): Angioedema
Frequency not reported: Purpura, eczema, furunculosis, pruritus, rash, maculopapular rash, sweating increased[Ref]


Common (1% to 10%): Viral infection
Uncommon (0.1% to 1%): Hypersensitivity
Frequency not reported: Herpes simplex, otitis externa, otitis media[Ref]


Common (1% to 10%): BUN increased
Uncommon (0.1% to 1%): Creatinine increased
Frequency not reported: Renal calculus
Postmarketing reports: Impaired renal function, renal failure[Ref]


Common (1% to 10%): Urinary tract infection
Frequency not reported: Glycosuria, albuminuria, cystitis, hematuria, micturition frequency, polyuria, urinary incontinence[Ref]


Common (1% to 10%): Depression
Frequency not reported: Anxiety, insomnia, nervousness[Ref]


Uncommon (0.1% to 1%): ALT greater than 3.5 times the upper limit of normal
Frequency not reported: Serum glutamic oxaloacetic transaminase (SGOT) increased, serum glutamic pyruvic transaminase (SGPT) increased, ALT increased, AST increased, alkaline phosphatase increased[Ref]


Frequency not reported: Conjunctivitis, vision abnormal, xerophthalmia[Ref]


1. Cerner Multum, Inc. "Australian Product Information." O 0

2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

3. "Product Information. Teveten (eprosartan)." SmithKline Beecham, Philadelphia, PA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer